Regeneron Pharmaceuticals ... accelerates the traditional drug development process through its proprietary VelociSuite technologies such as VelocImmune, which uses unique genetically humanized ...

Meanwhile, discussing the company’s VelociSuite technologies, Christos Kyratsous, PhD, senior vice president of research at Regeneron, said the application of those technologies “to address ...

Regeneron Pharmaceuticals ... The company utilizes proprietary technologies like VelociSuite, to produce optimized human antibodies and bispecific antibodies. Its marketed products include ...

Regeneron Pharmaceuticals ... The company’s cutting-edge VelociSuite technology, which speeds up drug research and genetic medicine development and aids in converting scientific discoveries ...